Skip to content
Recall Observatory FDA recall evidence

Drug product

Paroxetine Extended-Release Tablets USP, 12.5 mg, 30 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC: 68180-647-06

D-0974-2017

June 22, 2017

Class III

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 77606
Status
Terminated
Classification
Class III
Quantity
12480 bottles
Official record key
drug-enforcement:D-0974-2017

Official wording

Reason: Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study.

Code information: Lots: H605712, H605711, H605710, EXP November 2018; H702255, H702202 EXP March 2019

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification